Accessibility Menu
Omid logo

Omid(OTC) OMID

Current Price$0.02
Market Cap$1.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)+76%
5 Year-76%
1 Year+16%
1 Month-48%
Omid last closing stock price
MetricPriceDate
Last closeUSD 0.022026-07-23
Omid stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-33.04%USD 0.032026-07-16
1 month-47.67%USD 0.042026-06-17
3 month-67.42%USD 0.062026-04-22
Year to date-33.28%USD 0.032025-12-31
1 year+15.87%USD 0.022025-07-21
3 year-76.71%USD 0.082023-07-24
5 year-75.81%USD 0.082021-07-23
Since inception+75.91%USD 0.012020-02-18

Omid Financials at a Glance

Market Cap

$1.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$394.12K

Net Income (TTM)

-$177.93K

EPS (TTM)

-$0.00

P/E Ratio

-10.75

Dividend

$0.00

Beta (Volatility)

0.78 (Low)

Price

$0.02

Volume

110

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.00 - $0.07

Estimated Earnings Date

Jun 3, 2026

OMID News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Omid

OMID Holdings, Inc. operates within the health and wellness sector, focusing on the creation and distribution of CBD-infused products. Based in Phillipsburg, New Jersey, the company aims to leverage the growing demand for health-oriented solutions.

Products and Services
  • CBD-infused wellness products targeting health-conscious consumers
  • Innovative formulations designed for various health applications
  • Distribution channels that enhance product accessibility
Growth Outlook
  • Significant increase in quarterly revenue, reaching $93,087 in Q4 2025
  • Strong cash position with $41,405 in cash and cash equivalents
  • Potential market expansion as CBD products gain popularity
Financial Highlights
  • Trailing twelve months (TTM) revenue of $399,119
  • Current ratio of 28.80 indicates strong liquidity
  • Net income of $37,793 reported in Q4 2025, showing positive momentum
OMID Holdings, Inc. is positioned in a rapidly growing industry, with a focus on health and wellness through CBD products. The recent quarterly performance indicates a positive trend, with a notable increase in revenue and a solid cash position. The company's strong liquidity suggests it can navigate operational challenges effectively. As the market for CBD products continues to expand, OMID Holdings may benefit from increased consumer interest and demand. Investors may find the company's innovative approach and financial resilience appealing as it seeks to capitalize on growth opportunities in the health and wellness sector.
AI Generated • Jul 1, 2026

Industry

Pharmaceuticals

Employees

6

CEO

Frank Adam

Headquarters

Phillipsburg, NJ 8865, US

OMID Financials

Key Financial Metrics (TTM)

Gross Margin

-16.82%

Operating Margin

-80.21%

Net Income Margin

-45.15%

Return on Equity

-70.10%

Return on Capital

-78.14%

Return on Assets

-42.53%

Earnings Yield

-9.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

96.36M

Volume

110

Avg. Volume

8.87K

Financials (TTM)

Gross Profit

-$66.28K

Operating Income

-$316.12K

EBITDA

-$345.54K

Operating Cash Flow

-$130.20K

Capital Expenditure

$4.00

Free Cash Flow

-$130.19K

Cash & ST Invst.

$292.04K

Total Debt

$324.49K

Omid Performance Analysis

Omid annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,551,937-27.8%
20232023-12-31USD 522,237-66.3%
20242024-12-31USD 247,591-52.6%
20252025-12-31USD 394,11959.2%
Omid sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-90.0%
Q22025-06-301428.8%
Q32025-09-3012.4%
Q42025-12-31-39.8%
Omid annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.00N/A
20232023-12-31USD 0.00N/A
20242024-12-31USD -0.01N/A
20252025-12-31USD -0.00-79.5%
Omid sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-3131.0%
Q22025-06-30105.0%
Q32025-09-30N/A
Q42025-12-31300.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$93.09K

+3.4%

Gross Profit

$39.59K

+1176.5%

Gross Margin

42.53%

N/A

Market Cap

$1.86MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$310.75K

N/A

Employees

6

N/A

Net Income

$37.79K

+113.7%

EBITDA

-$41.85K

+72.2%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$292.04K

-54.8%

Total Debt

$324.49K

-2.8%

Accounts Receivable

$2.03K

N/A

Inventory

$103.11K

-28.0%

Long Term Debt

$324.49K

-2.8%

Short Term Debt

$0.00

N/A

Return on Assets

-42.53%

N/A

Return on Invested Capital

-78.14%

N/A

Free Cash Flow

-$2.51K

+97.9%

Operating Cash Flow

-$2.51K

+97.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
PLSHPanacea Life Sciences Holdings, Inc.
$0.08+0.00%
SHMNSOHM, Inc.
$0.00+0.00%
HEMPHemp, Inc
$0.00+0.00%
FWDGFutureWorld Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About OMID

What is the current price of Omid?

Omid is trading at $0.02 per share.

What is the 52-week range for Omid?

Over the past 52 weeks, Omid has traded between $0.00 and $0.07.

How much debt does Omid have?

As of the most recent reporting period, Omid reported total debt of $324.49K.

How much cash does Omid have on hand?

Omid reported $41.41K in cash and cash equivalents in its most recent financial results.

What is Omid’s dividend yield?

Omid does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.